Menopausia Definició y características

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

T h e M e n o p a u s a l Tr a n s i t i o n

Janice L. Bacon, MD, FACOG

KEYWORDS
 Menopause  Perimenopause  Hormones

KEY POINTS
 Symptoms of menopause often begin 4 to 6 years before the cessation of menses and
persist for years.
 Loss of ovarian hormones has widespread and often adverse effects on many organ
systems.
 Therapy for menopausal symptoms must be individualized.

Menopause occurs when the ovaries have complete (or near-complete) follicular
exhaustion, resulting in very low serum levels of estradiol and markedly increased
follicle-stimulating hormone (FSH) levels. Common symptoms of menopause
(Box 1) often begin during the perimenopausal transition at a median of 47 years or
4 to 6 years before menopause occurs. Because other medical disorders which occur
frequently with aging exhibit some of the same symptoms as those of menopause,
women may have difficulty distinguishing when they enter the menopausal transi-
tion-.This is also true for women who have had irregular menses, an endometrial abla-
tion or a hysterectomy. Symptoms continue for several years after menopause and
some women continue to have vasomotor symptoms for even longer periods of
time. Almost all women with an intact uterus experience menstrual irregularity in the
menopausal transition years resulting from hormonal fluctuations before ovarian follic-
ular depletion.
The largest longitudinal study of women’s endocrine and clinical manifestations of
menopausal transition comes from the Study of Women’s Health Across the Nation
(SWAN).1 This research evaluated and followed more than 3000 women from diverse
communities, aged 42 to 52 years, for 15 years. Scientific areas of study for SWAN
included bone mineral density and body composition, cardiovascular measures and
risk factors, and ovarian markers. Ovarian aging was assessed by serial assessment
of FSH, luteinizing hormone, estradiol (E2), inhibin-B, and estrone (E1). Inhibins are
peptides of the transforming growth factor family and are produced by granulosa cells
of the ovarian follicle. Inhibin levels decline during menopause because of the negative

Disclosure: No disclosure relevant to this topic.


Women’s Health and Diagnostic Center, 2728 Sunset Boulevard, Lexington Medical Park 1,
Suite 106, West Columbia, SC 29169, USA
E-mail address: [email protected]

Obstet Gynecol Clin N Am 44 (2017) 285–296


http://dx.doi.org/10.1016/j.ogc.2017.02.008 obgyn.theclinics.com
0889-8545/17/ª 2017 Elsevier Inc. All rights reserved.

You might also like